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Abstract  
Zinc was selected as a priority micronutrient for EURRECA, because there is significant 
heterogeneity in the Dietary Reference Values (DRVs) across Europe.  In addition, the 
prevalence of inadequate zinc intakes was thought to be high among all population groups 
worldwide, and the public health concern is considerable. In accordance with the EURRECA 
consortium principles and protocols, a series of literature reviews were undertaken in order to 
develop best practice guidelines for assessing dietary zinc intake and zinc status.  These were 
incorporated into subsequent literature search strategies and protocols for studies 
investigating the relationships between zinc intake, status and health, as well as studies 
relating to the factorial approach (including bioavailability) for setting dietary 
recommendations. EMBASE (Ovid), Cochrane Library CENTRAL and MEDLINE (Ovid) 
databases were searched for studies published up to February 2010 and collated into a series 
of Endnote databases that are available for the use of future DRV panels. Meta-analyses of 
data extracted from these publications were performed where possible in order to address 
specific questions relating to factors affecting dietary recommendations. This review has 
highlighted the need for more high quality studies to address gaps in current knowledge, in 
particular the continued search for a reliable biomarker of zinc status and the influence of 
genetic polymorphisms on individual dietary requirements.  In addition, there is a need to 
further develop models of the effect of dietary inhibitors of zinc absorption and their impact 
on population dietary zinc requirements.   
 
Key words: Zinc, Dietary recommendations, Zinc intake, systematic review, zinc status, zinc 
bioavailability, zinc requirements. 
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Introduction 
Zinc is well established as an essential micronutrient for human health, having numerous 
structural and biochemical functions at the cellular and sub-cellular level, including enzyme 
function, DNA and RNA metabolism, protein synthesis, gene expression, cell growth and 
differentiation, and cell mediated immunity. Inadequate zinc intake has profound 
consequences at all points of the human lifecycle from the point of conception through to old 
age. Zinc was selected as a priority micronutrient for EURRECA, because the prevalence of 
inadequate zinc intakes was thought to be high among all population groups, and the public 
health concern is considerable. In addition, new scientific evidence has recently become 
available that demonstrates a large heterogeneity among current recommendations on zinc 
intake across Europe (Cavelaars et al., 2010; Doets et al., 2008) (See Activity 1 in 
(Dhonukshe-Rutten et al., 2013). 
The total amount of zinc present in the adult human body ranges from 1.5 to 2.5mg, most of 
which is intracellular, within skeletal muscle tissue (57%), bone (29%) and other tissues 
including skin and organs (Jackson, 1989). The zinc located within these tissues has a 
relatively slow turnover rate and is not readily responsive to changes in dietary zinc intake. 
Kinetic studies suggest that only a small proportion of total body zinc (approximately 10%) 
represents the “functional pool” of zinc, which is comprised of zinc, located within the liver 
and other tissues, that exchanges rapidly with the plasma, and when this functional pool is 
depleted zinc deficiency ensues (King, 1990). Zinc deficiency in adults can lead to dermatitis, 
hair loss, diarrhoea, loss of appetite, reproductive failure, hypogeusia, loss of cognitive 
function, susceptibility to infections and depressed immune function (Shankar and Prasad, 
1998), delayed wound healing and depression (Andrews and Gallagher-Allred, 1999).  Zinc 
deficiency has also been associated with three major health diseases prevalent in Europe: 
Diabetes, cancer and coronary heart disease (Singh et al., 1998). Zinc deficiency may be a 
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serious public health problem that compromises the development of millions of children 
(Sandstead and Smith, 1996). The recent Lancet series on maternal and child under nutrition 
concluded that zinc deficiency is responsible for about 4% of child mortality and disability-
adjusted life-years (Black et al., 2008). The consequences and manifestations of severe zinc 
deficiency in infants and children and adolescents can be retardation of linear growth and 
development, poor appetite, delayed sexual maturation and hypogonadism, frequent 
infections (Maret and Sandstead, 2008), alopecia, dermatitis, delayed wound healing, 
diarrhoea, pneumonia, malaria (Fischer Walker et al., 2009), limitation on the senses of taste 
and smell, night blindness (Christian et al., 2001; Seiler et al., 2002). Zn deficiency may be 
associated with deficits in activity, attention, and motor development (Bhatnagar and Taneja, 
2001). Results of several studies indicated that supplementation with zinc can significantly 
reduce the rates of diarrhoea and pneumonia in young children and increase the growth rate 
of stunted children (Brooks et al., 2005a; Brooks et al., 2005b; Brown et al., 2002). During 
the acute diarrhoea,  zinc supplementation reduces the duration and severity of the disease, so 
that now the WHO recommends zinc supplementation as an adjunct to rehydration therapy, to 
replace the excessive losses of zinc during periods of diarrhoea (WHO). The involvement of 
maternal zinc status in pregnancy outcome is still unclear, animal models have shown that 
severe maternal zinc deficiency results in impaired implantation, abortions and foetal 
malformations (Keen et al., 2003). The consideration that zinc deficiency is a teratogenic risk 
in humans may be supported by the correlation of low plasma zinc concentrations in the first 
and third trimesters of pregnancy with an increased risk for malformations and low birth 
weight (LBW), respectively. Zinc deficiency is thought to influence embryonic and foetal 
development through reduced cell proliferation, or reduced protein synthesis or reductions in 
rates of tubulin polymerization rather than increased rates of cellular oxidative damage or 
increased rates of apoptosis and reduced binding of hormones and transcription factors 
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dependent on zinc-finger regions (Jankowski-Hennig et al., 2000; Mackenzie et al., 2002; 
WHO). 
Current dietary recommendations 
Dietary recommendations for zinc intake have been mainly based on balance studies focusing 
on the prevention of deficiency and use the factorial approach which assumes that the zinc 
requirement is the lowest intake which replaces obligatory zinc endogenous loss. The method 
computes the dietary zinc requirement by dividing the endogenous zinc loss by the fractional 
zinc absorption (King, 1986). In Europe and in other non-European countries, zinc 
recommendations for infants are generally set either based on zinc concentration of breast 
milk, using a factorial approach or extrapolating values from those given for adults. 
There is significant heterogeneity among current recommendations on zinc intake across 
Europe and worldwide (Doets et al., 2008). Table 1 illustrates the range of dietary zinc 
recommendations for various countries worldwide. This heterogeneity is due to a number of 
factors including the data used to derive the value, and differences in expert opinion between 
panels convened to review the data. 
 
Current European intakes  
As part of the EURRECA programme of work, Roman-Vinas et al undertook an analysis of 
population dietary surveys from across Europe in order to determine the prevalence of 
inadequate nutrient intake in Europe using the Nordic Nutritional Recommendations as the 
standard (Roman-Vinas et al., 2010). This study revealed that the failure to meet the EAR 
(estimated average requirement) of 6.4mg/day or 5.7mg/d for adult males and female 
respectively was greatest in Ireland with dietary zinc intakes falling below this cut off value 
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in 11.9% men and 28.8% women. A similar picture emerged for elderly people (aged >64 
years), with those living in Ireland having the highest percentage failing to meet the EAR,  
13.6% and 13.1% of elderly men and women respectively (Vinas et al., 2011) 
 A review of available micronutrient intake and status data in Europe (Novakovic R, 
Submitted 2011) showed that data on intake of zinc were very limited for all life stages, so no 
cross country comparison could have been made. However, available data for zinc status 
(based on serum/plasma zinc concentrations) in children, adolescents and adults showed no 
regional differences when Central and Eastern Europe, Scandinavia, Western and 
Mediterranean countries were compared. All levels were within the optimal range indicating 
adequacy in zinc status (Novakovic R, Submitted 2011).  
 
A systematic review of the relationship between micronutrient intake and socioeconomic 
determinants in Europe revealed that there were almost no differences in zinc intake between 
different socioeconomic status (SES) groups. On the other hand, status data in adults showed 
5% higher serum zinc level in the low SES group. In comparison to reference values (Nordic 
nutrient recommendations for intake and the WHO for status ( de Benoist et al., 2007)), all 
observed intake and status levels were within the optimal range, with the exception of levels 
of the low SES group in UK children (Novakovic R, Submitted 2012) 
 
On an individual basis, an inadequate dietary intake of zinc could be the result of a strict 
vegan diet, a diet which is primarily based on grain products (Solomons and Slavin, 2001) or 
through a restrictive diet due, for example, to anorexia or alcohol or drug addiction. Certain 
disease states such as acrodermatitis enteropathica, Celiac disease, Crohn’s disease and 
ulcerative colitis may disrupt the absorption of zinc  (Solomons and Slavin, 2001). Other 
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health states may increase zinc losses primarily through diarrhoea, or increase requirements, 
such as the post-operative state (Solomons and Slavin, 2001). 
The purpose of this review is to provide a summary of the methods used, and the results 
obtained from the systematic literature searches and subsequent meta-analysis of the data 
retrieved that were performed by partners in the EURRECA network of excellence. These 
activities were designed to answer specific questions regarding zinc-intake-status 
relationships. In addition, a comprehensive review of the factorial approach to setting zinc 
recommendations was undertaken.  The overall aim of these activities was to generate new 
data and approaches that could assist future panels to derive dietary zinc recommendations 
using robust and transparent methodology.  
Methods 
Assessing dietary zinc intake: 
One of the initial activities in the EURRECA process was to establish the most robust 
methodology of assessing zinc intake and status ((Matthys et al., 2010) and activity 3 in 
(Dhonukshe-Rutten et al., 2013)). The accurate determination of dietary micronutrient intake 
is notoriously problematic. Following a series of reviews of the methods used to assess 
micronutrient intake in Europe (Serra-Majem L, 2009) best practice guidelines were 
developed and adopted by the EURRECA network for all subsequent nutrient review 
activities. These are described in detail in “RA1.1 Best practice guidelines” in 
www.eurreca.org. In summary, only studies that used the following methodologies were 
included in the systematic reviews:   
1) validated FFQ/Dietary History 
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2) validated 24h recall / food records / diary measurements for at least 3 days 
3) validated 24h recall / food records / diary measurements < 3 days with adjustment for 
intra-individual variability 
Since interventions commonly involve supplements, these were considered, taking into 
account the possible differences in bioavailability. 
Assessing zinc status: 
The assessment of zinc status is also problematic and it is generally accepted that there is 
currently no specific, reliable biomarker of zinc status. A systematic review and meta-
analysis of the literature examining the efficacy of potential biomarkers of zinc status was 
undertaken (Lowe et al., 2009). This review presented an analysis of data from over 32 
potential biomarkers however for many there was insufficient evidence to assess their 
reliability (Table 2) 
Table 2. Biomarkers identified in systematic review (Lowe et al., 2009) 
Plasma/serum zinc concentration was the most commonly used marker of zinc status and 
therefore the biomarker for which there were most data. It was found to respond to both 
increases and decreases in zinc intake, and was identified as being a useful biomarker 
however there are considerable reservations due to the effect of multiple confounders, such as 
infection, inflammatory status and time of last meal. Urine and hair were also considered 
useful biomarkers. 
Health outcomes associated with inadequate zinc intake: 
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Important health problems related to zinc intake in adults and elderly people were identified 
by a literature search. These include: compromised immunity, dermatitis, hypogeusia, 
impaired cognitive functioning (dementia), depression, diabetes (reduced glucose tolerance), 
ischemic heart disease, carcinogenesis and anorexia. These were discussed and prioritized by 
the experts in zinc research within the RA2 team (Matthys C, 2011). Prioritisation was based 
on the strength of evidence of the deficiency and role of zinc on the health outcome, the 
relevance of the health outcome to the European population groups and the amount of 
evidence based research literature available based on a pilot literature search. The health 
outcomes that were identified for each population group are shown in Table 3, and are listed 
in order of priority.   
Table 3. Priority health outcomes associated with inadequate zinc intake for each 
population group. 
The best practice guidelines were then used to design the search protocols for the subsequent 
systematic reviews of the zinc intake- status- health relationships, the factorial approach for 
assessing dietary zinc requirements, zinc bioavailability and the influence of polymorphisms 
on zinc requirements. [Details of the search protocols can be found at: www.eurreca.org] 
 
Results 
Factorial approach and bioavailability 
A technique commonly used when setting dietary zinc recommendations is the factorial 
approach which combines zinc required to replace obligatory losses with additional needs for 
zinc during different stages in the life cycle and makes adjustments for the bioavailability of 
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zinc in the diet (See Table 3 in (Dhonukshe-Rutten et al., 2013). Additional needs for zinc 
during different stages of life include that required for foetal growth during pregnancy, 
lactation and growth through infancy to adulthood. Literature searches were therefore 
designed to answer the following research questions: What are the key factors that affect zinc 
losses in all population groups? What are the key factors that affect zinc gains in all 
population groups? What are the additional needs for zinc during pregnancy, lactation and for 
growth?  How well is zinc absorbed from meals and whole diets? 
All titles and abstracts were screened for potential relevance and sorted into the population 
groups; infants, children and adolescents, pregnant and lactating women, adults, and elderly 
people as defined by the EURRECA consortium (See Activity 1 in (Dhonukshe-Rutten et al., 
2013). An EndNote library was created compiling all the papers that met the inclusion 
criteria. The data regarding zinc losses and gains were extracted and collated using Excel 
(Microsoft Office Excel 2003). The quality and the risk of bias were assessed as indicators of 
validity. The studies included in this review were checked for a minimum quality score 
system developed by the EURRECA consortium which was adapted from The Cochrane 
Handbook for Systematic Reviews
 
(Higgins and Green, 2008).  
Factors affecting zinc losses and gains 
 From a total of 491 abstracts retrieved from electronic and hand searches, 105 appeared 
potentially relevant studies and were assessed for inclusion once the full paper had been 
obtained. Seventy-two papers were finally considered relevant across all population groups 
(adults and elderly, infants, children and adolescents, and pregnant and lactating women, 
adults and elderly). Despite the relatively stringent inclusion criteria, the included studies 
displayed a broad variety of methodological approaches, and were therefore unsuitable for 
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meta-analysis.  Therefore the data extracted from the papers were tabulated and summarised 
narratively (Silvia Bel-Serrat, In Progress).  Overall, balance studies have shown that zinc 
losses and gains are a function of the initial zinc status of an individual, the amount of 
bioavailable zinc in the diet and are modulated by homeostatic mechanisms. That means that 
dietary zinc recommendations should be estimated on the basis of the target population diet 
making difficult the possibility of establishing a value valid for the entire population. In 
addition, age, physical activity level, malabsorption syndromes, disease status can all affect 
zinc losses and gains.  Moreover, interactions among nutrients should be also taken into 
account as they may also play an important role by means of affecting zinc utilization. As 
suggested by Taylor et al. (1991), the interaction between these homeostatic changes and zinc 
availability from different dietary sources should be better characterized to improve the 
accuracy of dietary zinc recommendations.   
Factors affecting zinc bioavailability 
The systematic review identified 120 studies as relevant to the research question of which 87 
studies were conducted in adults and elderly, 2 in pregnancy and lactating women, 14 in 
children and adolescents and 17 in infants. Potential modifiers of zinc bioavailability were 
identified as illustrated in Figure 1. Phytate was the most frequently investigated modifier of 
zinc absorption. Twenty four estimates from seventeen studies that investigated the effect of 
dietary phytate level on zinc absorption were combined in a random effects meta-analysis.  A 
forest plot showing the overall effect size of high versus low dietary phytate intake on zinc 
absorption is shown in Figure 2. The mean difference in fractional zinc absorption between 
low and high phytate diets was 0.11 (95% CI: 0.07, 0.16) however there was a high degree of 
between study heterogeneity (I
2
 94% , P<0.0001). Further analysis of this data set is 
underway to examine the factors that contribute to this heterogeneity and the overall effect of 
phytate:zinc molar ratio on zinc absorption.  
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The influence of gene polymorphisms zinc metabolism 
The primary aim of this activity was to generate a database containing relevant information 
related to the impact of functional gene polymorphisms on zinc metabolism.  Specifically, 
this involved identifying data assessing the impact of functional polymorphisms (e.g. single 
nucleotide polymorphisms, or SNPs) on micronutrient status biomarkers and associated 
health outcomes. The research questions used to develop the search protocol were: How do 
genetic polymorphisms affect zinc status? Are there any interactions between functional 
polymorphisms which affect zinc status and various health outcomes? Information was 
collated from studies of individuals who are either homozygous, heterozygous or wild type 
for specific polymorphisms. Where data exists for zinc status, functional polymorphisms and 
linked health outcome, this information was also recorded. Data were collated from all 
population groups including infants, children, adolescents and adults including the elderly 
into a database that is available at www.eurreca.org.  
Of the 167 papers identified by the systematic search of the literature databases, 12 papers 
met the inclusion criteria and reported statistically significant results for altered zinc 
biomarker status in groups of people with differing gene variants.   The gene interleukin 6 
which regulates the amount of circulating proteins involved in inflammatory responses 
associated with hyperglycaemia and non-insulin dependent diabetes mellitus  and coronary 
artery disease is thought to be influenced by zinc status (Giacconi et al., 2006; Giacconi et al., 
2005). Two papers    reported a relationship between SNP’s of the Interleukin 6 gene and 
plasma zinc concentration and health outcomes, including  perceived stress scale (PSS), 
geriatric depression scale (GDS) and mini mental state examination (MMSE) (Mariani et al., 
2008; Mocchegiani et al., 2008)..  
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Another gene angiotensin-converting enzyme (ACE) was also reported. An impaired zinc 
status can alter enzyme activity, with adverse effects on angiotensin- conversion from I to II 
affecting vasoconstriction and hypertension and subjects with the DD genotype 
polymorphism in the ACE gene have been shown to have the highest enzyme activity 
increasing the risk of hypertension (Tamura et al., 1996). Tamura et al found a significant 
correlation between plasma zinc concentration and ACE activity in pregnant women at 33 
weeks of gestation. However as this was the only significant correlation found in this study, it 
was stated that the significant result may have occurred by chance. 
The metallothionine gene has been included in the zinc database. Some polymorphisms of the 
metallothionein gene have been correlated to chronic inflammation and may affect zinc 
release (Mocchegiani et al., 2006; Richards et al., 2002). Another gene reported in the zinc 
database was apolipoprotein E (ApoE). Gonzalez et al (1999), reported that serum zinc 
concentrations in epsilon 4 ApoE carriers were significantly higher in patients with 
Alzheimer’s disease than in healthy control patients.  
The TP53 mutation in exon 5 through to 8, found in esophageal squamous cell carcinoma 
tumours was reported in a paper by Dar et al (2008). There is a notion that an imbalance of 
copper and zinc levels may lead to a higher prevalence of TP53 tumour mutations. Dar et al 
found that cancer patients with the TP53 tumour mutation had lower plasma zinc levels than 
those with no mutation.   
The glutathione S transferase (GST) gene was reported by 3 papers (Jin et al., 2011; Reszka 
et al., 2007; Reszka et al., 2005). The detoxifying enzyme GST metabolises tobacco smoke 
derived compounds; zinc deficiency therefore can increase the risk of mutations occurring 
and can decrease the activity of the antioxidant GST enzyme increasing the risk of some 
cancers including lung cancer. Some polymorphisms in the GST gene may be associated with 
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an elevated  risk of lung cancer and therefore the effect of zinc status on each variant allele 
needs to be investigated.   
The gene CYP1A1 was also investigated by Jin et al (2011). The CYP1A1 gene has a 
polymorphism at exon 7 where a new Mspl restriction site is introduced. The CYP1A1 gene 
is thought to influence metabolic activation and detoxification of some toxins and therefore 
can increase susceptibility to increasing risk of lung cancer. Jin et al reported that the risk of 
lung cancer decreased with a zinc level >1200ng/ml for both CYP1A1 variants and CYP1A1 
carriers suggesting that a higher concentration of serum zinc may protect against lung cancer. 
Haemoglobin H disease (HbH) was also included in the database and was thought to 
influence zinc status. Zinc deficiency is thought to be involved with impaired growth and 
hypogonadism traits observed in patients with polymorphic diseases such as the thalassemic 
diseases (Ajayi, 1997; Kajanachumpol et al., 1997) and cystic fibrosis (Van Biervliet et al., 
2007).  
The final gene reported as having a significant association with blood biomarker zinc status is 
SLC30A4 gene with a polymorphism on exon 5 915 T-C. The SLC30A4 gene encodes one of 
the zinc transport proteins and therefore it is thought that a polymorphism in this gene may 
affect zinc absorption and foetal development. Akar et al  (2006) studied  this gene and zinc 
status association and found that three hours after a zinc tolerance test there was a significant 
difference in plasma zinc level for TT and CC carriers,  indicating a functional property of 
this polymorphism. 
Table 5.  Results of the systematic search for studies of the effect of gene polymorphisms 
on zinc metabolism. 
Intake- status-health relationships 
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EURRECA is developing a method for the quantitative integration of evidence for deriving 
nutrient intake recommendations using bivariate dose-response relationships for intake-health 
(I-H) as well as intake-status (I-S) and status-health (S-H) relationships.  These data will be 
combined in a new integrated trivariate intake-status-health (I-S-H) dose-response model 
with data from classical nutrition studies and bioavailability factors (See Activity 6 in 
(Dhonukshe-Rutten et al., 2013). Search protocols were therefore designed to answer the 
following questions:  What is the effect of zinc intake on functional or clinical outcomes 
(intake-health) and what factors affect this relationship? What is the effect of zinc intake on 
indicators of exposure or body stores/biomarkers (intake-status) and what factors affect this 
relationship?  What is the effect of indicators of exposure or body stores (i.e. biomarkers) on 
functional or clinical outcome (status-health) and what factors affect this relationship? 
The result of the systematic search for studies addressing zinc intake status health 
relationships yielded over 1000 articles that were obtained in full text for eligibility 
evaluation. Due to the heterogeneity of the methodological approaches and outcome 
measures used in these studies, it is unlikely that meta-analysis of the data will be possible. 
 
Intake- status relationships 
Sufficient high quality RCT studies were identified to enable a meta-analysis of data 
describing the relationship between plasma zinc intake and plasma zinc concentration in each 
of the population categories. Units of measurement were converted to a standard form to 
facilitate comparison across studies. Intake-status regression coefficients ( ̂) were estimated 
for each individual study as described in detail elsewhere (Souverein et al., 2012).  An overall 
pooled  ̂ and SE( ̂) was calculated using random effects meta-analysis The statistical 
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transformations to obtain  ̂ s and SE( ̂)’s were performed using GenStat version 13-SP2 
(VSN International Ltd., http://www.vsni.co.uk/) and the meta-analysis was performed using 
STATA version 11.0 (College Station, TX), with statistical significance defined as P<0.05.  
For all population groups, with the exception of lactating women, the intake-status analyses 
revealed a positive and significant relationship between zinc intake and plasma zinc 
concentration, however a high degree of heterogeneity between the studies was observed 
(Table 4).  
Table 4: Results of the Meta-analysis of intake-status in all populations groups. 
Discussion 
The determination of dietary zinc recommendations has relied primarily on the factorial 
approach, with extrapolation to population groups for which data are limited or missing. A 
complementary approach involves examining the associations between dietary intake, status 
and health, to arrive at intakes that result in optimal status levels and are sufficient to prevent 
disease due to deficiency at one end of the spectrum, or toxic effects due to excess dietary 
zinc at the other end of the spectrum. The difficulty of this approach for zinc is the lack of a 
reliable and sensitive marker of zinc status, and the non-specific nature of the diseases 
symptoms associated with sub-optimal zinc intake. However, one of the overarching aims 
guiding the work described in this review was to gather the best quality data using the most 
robust methodology to provide a database for future panels to use when setting 
recommendations.   This included both a comprehensive review of the data available using 
both the classical factorial approach and a more novel intake-status-health association 
approach for zinc. 
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Regarding the factorial approach, a key factor that has been highlighted in this review and in 
discussion with experts is the need to consider bioavailability more closely as a modifier of 
the amount of dietary zinc required to meet requirements (Hambidge, 2010).  This review 
identified a broad range of dietary components that may impact on the amount of dietary zinc 
that is absorbed and utilised, the majority of which had a deleterious effect on zinc 
bioavailability (figure 1). Many of these food components require further studies to generate 
sufficient high quality data to enable conclusive evaluation of their effect at different levels of 
intake, however the most widely studied modifier of zinc absorption is dietary phytate.  This 
systematic review and meta-analysis confirms that phytate is a potent modifier of zinc 
absorption and should be taken into consideration when using the factorial approach to 
setting dietary zinc recommendations for any given population. Mathematical models that 
combine the effects of varying levels of phytate and zinc intake on true zinc absorption are 
potentially valuable tools in this process.  A trivariate model (zinc intake-absorption-phytate 
intake), published by Hambidge et al in 2010 has helped to explain much of the variability of 
zinc absorption from human diets (Hambidge et al., 2010). This mathematical model is based 
on the accepted view that zinc absorption is a carrier-mediated process, phytate inhibits 
absorption by binding with zinc in the gut to form an insoluble complex, and that dietary zinc 
and phytate are the primary dietary factors determining zinc absorption. The model predicts 
that the quantity of zinc absorbed from 40 mg dietary zinc at zero phytate intake is 6.4 mg 
Zn/d and that the dietary zinc intake required to meet the requirements for zinc doubles with 
every 1000 mg phytate consumed in the diet per day (Hambidge et al., 2010).  
Another potential modifier of the amount of dietary zinc needed to meet the requirement is 
genotype (Hambidge, 2010). This has been shown to have profound effects on the 
bioavailability of some micronutrients such as folate and iron (Casgrain et al., 2010). Most 
ZnT and Zip families show evidence of polymorphisms, which could produce structurally 
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different proteins and hence, transporter activity and /or specificity for zinc. Such 
polymorphisms could influence the amount of dietary zinc needed to meet the requirements 
and alter zinc metabolism (Cousins et al., 2006; Liuzzi and Cousins, 2004).  The systematic 
search for studies on micronutrient metabolism yielded a very small number of relevant 
studies.  This is clearly an important area for future research development. 
Investigation of the zinc intake-status relationships in some population groups yielded some 
potentially useful new data. A dose-response curve was constructed from the extracted data, 
where the slope was based on the pooled  ̂  from the meta-analysis of the RCTs expressed on 
a loge-scale. Reported means and standard deviations of zinc intake and zinc status were 
extracted from the observational studies and was used to estimate the intercept of this curve 
(See Activity 6 in (Dhonukshe-Rutten et al., 2013). The dose response curves for the Adult 
and Elderly, and the Pregnant and Lactating women population groups are shown in Figure 3 
and Figure 4 respectively.  These data can be used as complementary evidence for 
underpinning zinc reference values, however, the limitations of serum/plasma zinc 
concentration as a biomarker for zinc status should be acknowledged. Serum/plasma zinc is 
recognised as being a relatively insensitive index of zinc nutritional status due to efficient 
homeostatic regulation which responds to alterations in zinc intake, up-regulating absorption 
and conserving losses via the gastrointestinal tract and kidneys when intakes fall. In addition, 
whilst all studies included in the analysis were undertaken in apparently healthy individuals, 
factors such as stress, infection and inflammation, which are known to affect plasma zinc 
concentrations, may have gone unreported. Unfortunately, more sensitive indexes of zinc 
status have yet to be identified and plasma serum zinc remains by far the most commonly 
used biomarker of zinc status (Lowe et al., 2009). It is anticipated that this approach may be 
used to model the relationships between zinc intake or status with the health outcomes for 
zinc, and that these can be combined with the intake status relationships described above to 
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form a trivariate model of intake status and health (See Activity 6 in (Dhonukshe-Rutten et 
al., 2013).  It is unclear at the moment whether or not our systematic searches have yielded 
sufficient data to enable this but it is likely that further studies are required.   
This process has highlighted the need for more high quality studies to address gaps in current 
knowledge.  Some of the key issues that came out of EURRECA workshops through 
discussion  with experts external to the EURRECA Network focussed around zinc 
bioavailability and the need to model the effect of inhibitors of zinc absorption such as 
phytate, calcium and iron (Casgrain et al., 2010).  Most current knowledge of zinc 
homeostasis is based on research in healthy adult males. In order to avoid scaling efforts 
should be made to obtain data on both genders at all ages, including pregnancy and lactation. 
In particular there is a paucity of data from studies in young children which necessitates the 
use of scaling to arrive at dietary recommendations, where this is the only option, there needs 
to be consensus regarding which growth/weight data to use. 
In summary, a series of systematic reviews and meta-analyses were conducted in accordance 
with the protocols and procedures developed by the EURRECA consortium.  This process 
has gathered together information relating to the setting dietary zinc recommendations which 
will be available as a valuable resource for future DRV panels.  It has also generated new 
intake-status-health association data that may be used in combination with the classical 
factorial approach to model dietary zincs necessary to meet physiological requirements. This 
process has also highlighted the key areas for further research, in particular the urgent need 
for a reliable biomarker of zinc status, the further development of models of the impact of 
dietary factors on zinc bioavailability and the influence of genetic polymorphisms on 
individual dietary requirements.   
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Figure 1.  Flow diagram showing the results of the systematic review of studies 
investigating zinc bioavailablity. 
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 Figure 2 . Forest plot of high and low phytate meals and zinc absorption as % of the 
diet. 
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Figure 3. Serum/plasma zinc concentration (µmol/L) as a function of dietary zinc intake 
(mg/day), estimated by random-effects meta-analyses of RCTs. In figure 3a the data are 
presented on natural log scale, where Y=0.11*x+2.28. 
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Figure 4 Serum/plasma zinc concentration (µmol/L) as a function of dietary zinc intake 
(mg/day), estimated by random-effects meta-analyses of RCTs of pregnant (solid line) and 
lactating (dashed line) women. In figure 4a the data are presented on natural log scale.  
4a 
 
  4b. 
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Table 1. -  Selected recommended intake levels for zinc (mg) 
DATA 
SOURC
E 
 
Gend
er 
Special 
condition
s 
POPULATION GROUP 
Infant
s 
Childr
en 
Adolesce
nts 
Adult
s 
 
Elderl
y 
Lactati
on 
Pregnan
cy 
WHO / 
FAO 
Male High 
bioavailabil
ity 
0-6m    
1.1 
7-
12m  
0.8 
1-3y   
2.4 
4-6y   
2.9 
7-9y   
3.3 
10-18y   
5.1 
 
19-
65y  
4.2 
>65y  
4.2 
- - 
Femal
e 
Low 
bioavailabil
ity 
0-6m    
6.6 
7-
12m  
8.4 
1-3y    
8.3 
4-6y    
9.6 
7-9y   
11.2 
10-18y  
14.4 
 
 
19-
50y  
9.8 
 
>65y  
9.8 
0-3m   
19 
< 3m.  
11 
Nordic 
(Norwa
y) 
Male - <6m    
NUL
L 
6-
11m 
5 
2-5y     
6 
6-9y     
7 
10-13y 
11 
14-17y    
12 
18-
30y   
9 
31-
60y   
9 
≥75y  
9 
- - 
Femal
e 
- <6m   
NUL
L 
6-
11m 
5 
2-5y     
6 
6-9y     
7 
10-13y 
8 
14-17y     
9 
18-
30y   
7 
31-
60y   
7 
≥75y  
7 
- - 
Australi
a / NZ 
Male - 0-6m    
2 
7-
12m  
3 
1-3y    
3 
4-8y    
4 
9-13y  
6 
14-18y    
13 
19-
30y  
14 
31-
50y  
14 
>70y 
14 
- - 
Femal
e 
- 0-6m    
2 
1-3y    
3 
14-18y     
7 
19-
30y   
>70y   
8 
14-18y   
11 
14-18y    
10 
40 
 
7-
12m  
3 
4-8y    
4 
9-13y  
6 
8 
31-
50y   
8 
19-50y   
12 
19-30y    
11 
DACH 
(German
y) 
Male - 0-3m    
1 
4-
11m  
2 
1-3y    
3 
4-6y     
5 
7-9y     
7 
10-12y 
7 
13-14y  
9.5 
15-18y  
10 
 
19-
64y  
10 
 
 
≥65y   
10 
- - 
Femal
e 
- 0-3m    
1 
4-
11m  
2 
1-3y     
3 
4-6y     
5 
7-9y     
7 
10-12y 
7 
13-14y  7 
15-18y  7 
19-
64y   
7 
 
≥65y    
7 
      10 >4m     
10 
EC Male - 6-
11m  
4 
1-3y     
4 
4-6y     
6 
7-10y   
7 
11-14y  9 
15-17y  9 
≥18y   
9.5 
≥18y  
9.5 
- - 
Femal
e 
- 6-
11m  
4 
1-3y     
4 
4-6y     
6 
7-10y   
7 
11-14y  9 
15-17y  7 
≥18y    
7 
 
≥18y   
7 
 
       12 7 
IOM 
(US/ 
Canada
) 
Male - 0-6m    
2 
7-
12m  
3 
1-3y     
3 
4-8y     
5 
9-13y   
8 
14-18y 11 19-
70y  
11 
>70y  
11 
- - 
Femal - 0-6m    1-3y     14-18y  9 19- >70y  14-18y  19-30y  
41 
 
e 2 
7-
12m  
3 
3 
4-8y     
5 
9-13y   
8 
70y  
8 
 
8 12 
19-30y  
12 
11 
31-50y  
11 
United 
Kingdo
m 
Male - 0-3m    
4 
4-6m    
4 
1-3y     
5 
4-6y     
6.5 
7-10y    
11-14y  9 19-
50y  
9.5 
>50y  
9.5 
- - 
 Femal
e 
- 0-3m    
4 
4-6m    
4 
1-3y    
5 
4-6y    
6.5 
7-10y  
7 
14-18y  9 19-
50y  
7 
 
>50y  
7 
NULL NULL 
 
 
Data presented in the Table was obtained from online EURRECA web resource 
NutriRecQuest: http://www.serbianfood.info/eurreca/ (Cavelaars et al., 2010) from original 
source documents (Australian Government Department of Health and Aging New Zealand 
Ministry of Health and National Health and Medical Research Council, 2005; Department of 
Health, 1991; Institute of Medicine, 2000; Ministry of Health Labour and Welfare Japan, 
2005; Nordic Council of Ministers, 2004; Scientific Committee for Food, 1993) 
† RDA, Recommended Dietary Allowance (USA, Japan); equivalent to RNI, Reference 
Nutrient Intake (UK);  PRI, Population Reference Intake (EFSA); RNI, Recommended 
Nutrient Intake (WHO/FAO); RDI, Recommended Dietary Intake (AU/NZ); RI, 
Recommended Intake (Nordic) 
*upper level of safe intake for European Community from EC2006, other EC data from 1993 
#Safe upper limit of selenium intake for UK from Expert Group on Vitamins and Minerals 
2003, Safe Upper Levels for Vitamins and Minerals Food Standards Agency (full document 
available at http://www.food.gov.uk/multimedia/pdfs/vitmin2003.pdf 
‘DACH’ refers to reference intakes for Germany, Austria and Switzerland 
‘Nordic countries’ refers to Denmark, Finland, Norway and Sweden. 
‘EC’ refers to European Community. 
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Table 2. Biomarkers identified in systematic review (Lowe et al., 2009). 
Potentially useful 
 
• Plasma/serum zinc concentration 
• Hair zinc concentration 
• Urinary zinc excretion 
 
Not useful 
 
• Erythrocyte zinc concentration 
• Mononuclear cell zinc 
concentration 
• Polymorphonuclear cell zinc 
concentration 
• Platelet zinc concentration 
• Plasma alkaline phosphatise activity 
 
Inconclusive due to lack 
of data 
 
 Aminolevulinic acid dehydratase 
 Erythrocyte metallothionein 
 Monocyte metallothionein cDNA 
 Salivary zinc 
 Salivary-sediment zinc 
 Mixed saliva zinc 
 Plasma extracellular superoxide dismutase 
 Lymphocyte zinc 
 Lymphocyte ecto-5’-nucleotidase 
 Nail zinc 
 Plasma angiotensin-converting enzyme 
 Neutrophil zinc 
 T lymphocyte metallothionein -2A mRNA 
 Plasma 5’-nucleotidase 
 Endogenous zinc excretion 
 Plasma zinc flux 
 Exchangeable zinc pool 
 Carbonic anhydrase 
 Fecal Zinc 
 Neutrophil α-D-mannosidase 
 Neutrophil alkaline phosphatase 
 Erythrocyte membrane zinc 
 Erythrocyte membrane alkaline phosphatase 
 Erythrocyte membrane neutral phosphatase 
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Table 3. Priority health outcomes associated with inadequate zinc intake for each population 
group. 
Infants Children & 
Adolescent 
Pregnant & lactating 
women 
Adults/Elderly 
 
Growth 
 
Immune 
response to 
vaccination 
 
Neurodevelopm
ent  
 
 
Growth 
 
Immune function 
 
Cognitive functions 
and Psychomotor 
development 
 
Dermatitis 
 
 
Foetus 
 
Foetal growth 
 
Foetal malformation  
 
Mother 
 
Preeclampsia 
 
Preterm delivery 
 
 
Immune function 
 
Cognitive function 
 
Dermatitis 
 
Anorexia  
 
Hypogeusia 
 
Ischemic heart 
disease  
 
Depression 
 
Diabetes Mellitus 
 
Carcinogenesis  
Table 4: Results of the Meta-analysis of intake-status in all populations groups. 
Population group Overall Beta 95% CI’s I2 p 
Adults and Elderly 0.09 0.07,0.12 79.1% P<0.0001 
Pregnant women 0.04 0.02, 0.07 55% p=0.002 
Lactating women 0.02 -0.01,0.05 0% p=0.28 
Children and adolescents 0.12 0.04, 0.20 97.6% p<0.005 
Infants 0.09 0.06,0.12 95% P<0.00001 
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Table 5.  Results of the systematic search for studies of the effect of gene polymorphisms 
on zinc metabolism. 
Author Year Reference 
Gene with significant 
interaction with Zn 
(Tamura et al.) 1996 
Obstet Gynecol 
88:497-502 
ACE insertion/deletion DD, 
DI and II 
(Mariani et al.) 2008 
Experimental 
Gerontology 
43:462-471 
MT1a +674 A/C transition 
and Interleukin 6 IL-6 
+174C/G transition 
(Gonzalez et al.) 1999 
Eur J Clin 
Investigation 
29:637-642 
Epsilon 4 apoE 
(Giacconi et al.) 2005 
Biogerontology 
6:407-413 
MT2A rs1610216 AA and 
AG, 246bp, 131 and 115bp 
(Dar et al.) 2008 
Nutrition and 
Cancer 60(5):585-
591 
TP53 mutation at exon 5-8 
(Reszka et al.) 2005 
Trace Elements 
and Electrolytes 
22(1):23-32 
GSTP1, GSTT1 and GSTM1 
(Jin et al.) 2011 
Cancer 
Epidemiology 
32:182-187 
CYP1A1 mspl Aa or aa and 
GSTM1null 
(Reszka et al.) 2007 
Genes Nutr 
2:287-294 
GSTM1 and GSTT1 
(Mocchegiani et al.) 2008 
Experimental 
Gerontology 
43:433-444 
IL-6 +174G/C 
(Kajanachumpol et 
al.) 
1997 
Southeast Asian J 
Trop Med Public 
Health 28(4):877-
880 
HbH, ß-thal/HbE, ß-thal 
major 
(Ajayi) 1997 
Trace Elements 
and Electrolytes 
14(2):69-71 
HbAA, HbSS, HbAS and 
HbAC 
(Akar et al.) 2006 
Trace Elements 
and Electrolytes 
23(4):266-269 
SLC30A4 ZNT4 915T-C at 
exon 5 
 
 
 
 
